Kumquat Biosciences
Kumquat Biosciences is a biotechnology company focused on developing innovative treatments for cancer, particularly targeting KRAS mutations that occur in various cancers such as pancreatic, colorectal, and lung cancers. The company recently gained attention for its partnership with Bayer, which is valued at up to $1.3 billion, aimed at advancing the development of a promising new cancer drug.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Iceland:
Kumquat Biosciences is responsible for initiating and completing research on the new cancer drug.
5